Ceridian HCM Stock Price, News & Analysis (NYSE:CDAY)

Ceridian HCM trades on the New York Stock Exchange (NYSE) under the ticker symbol "CDAY."

Ceridian HCM Holding Inc (NYSE:CDAY) released its quarterly earnings results on Tuesday, July, 30th. The company reported $0.12 EPS for the quarter, beating analysts' consensus estimates of $0.07 by $0.05. The firm had revenue of $196.30 million for the quarter, compared to analyst estimates of $192.29 million. Ceridian HCM had a return on equity of 2.34% and a net margin of 4.19%. The business's revenue was up 9.7% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.44) EPS. View Ceridian HCM's Earnings History.

Ceridian HCM is scheduled to release their next quarterly earnings announcement on Monday, November 4th 2019. View Earnings Estimates for Ceridian HCM.

Ceridian HCM updated its third quarter 2019 earnings guidance on Tuesday, July, 30th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $195-197 million, compared to the consensus revenue estimate of $198.68 million.

12 equities research analysts have issued 1-year price targets for Ceridian HCM's stock. Their predictions range from $37.00 to $65.00. On average, they expect Ceridian HCM's stock price to reach $57.09 in the next twelve months. This suggests a possible upside of 33.8% from the stock's current price. View Analyst Price Targets for Ceridian HCM.

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ceridian HCM in the last year. There are currently 5 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Ceridian HCM.

Media headlines about CDAY stock have trended somewhat negative this week, InfoTrie Sentiment reports. The research group rates the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Ceridian HCM earned a news impact score of -1.7 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for Ceridian HCM.

Ceridian HCM saw a drop in short interest in September. As of September 15th, there was short interest totalling 6,360,000 shares, a drop of 17.3% from the August 15th total of 7,690,000 shares. Based on an average daily trading volume, of 967,700 shares, the short-interest ratio is presently 6.6 days. Currently, 7.3% of the company's stock are short sold. View Ceridian HCM's Current Options Chain.

Some companies that are related to Ceridian HCM include Veeva Systems (VEEV), Synopsys (SNPS), Cadence Design Systems (CDNS), ANSYS (ANSS), Splunk (SPLK), Check Point Software Technologies (CHKP), Tableau Software (DATA), Twilio (TWLO), Symantec (SYMC), TAKE-TWO INTERACTIVE SOFTWARE (TTWO), Atlassian (TEAM), Citrix Systems (CTXS), SS&C Technologies (SSNC), Paycom Software (PAYC) and Okta (OKTA).

Based on aggregate information from My MarketBeat watchlists, some companies that other Ceridian HCM investors own include Workday (WDAY), Alteryx (AYX), CTR COAST MLP &/COM (CEN), Ferrellgas Partners (FGP), Costco Wholesale (COST), The Ultimate Software Group (ULTI), Five Below (FIVE), NVIDIA (NVDA), Union Pacific (UNP) and Adobe (ADBE).

(CDAY) raised $420 million in an IPO on Thursday, April 26th 2018. The company issued 21,000,000 shares at a price of $19.00-$21.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse and Deutsche Bank Securities served as the underwriters for the IPO and Barclays, Citigroup, Jefferies, CIBC Capital Markets, Wells Fargo Securities, Baird, Canaccord Genuity, Piper Jaffray, William Blair and MUFG were co-managers.

Ceridian HCM's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Zeke Capital Advisors LLC (0.01%), Strs Ohio (0.00%), Nelson Van Denburg & Campbell Wealth Management Group LLC (0.00%), Ingalls & Snyder LLC (0.00%) and Zurcher Kantonalbank Zurich Cantonalbank (0.00%). Company insiders that own Ceridian HCM stock include Arthur Gitajn, Cannae Holdings, Inc, David D Ossip, Lisa M Sterling, Ozzie J Goldschmied, Paul D Elliott, Scott A Kitching and Thomas H Lee Advisors, Llc. View Institutional Ownership Trends for Ceridian HCM.

CDAY stock was purchased by a variety of institutional investors in the last quarter, including Ingalls & Snyder LLC, Zeke Capital Advisors LLC, Nelson Van Denburg & Campbell Wealth Management Group LLC, Strs Ohio and Zurcher Kantonalbank Zurich Cantonalbank . View Insider Buying and Selling for Ceridian HCM.

Shares of CDAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CDAY stock can currently be purchased for approximately $42.67.

Ceridian HCM has a market capitalization of $6.11 billion and generates $746.40 million in revenue each year. The company earns $-63,400,000.00 in net income (profit) each year or ($0.05) on an earnings per share basis. Ceridian HCM employs 4,444 workers across the globe.View Additional Information About Ceridian HCM.

The official website for Ceridian HCM is http://www.ceridian.com/.

Ceridian HCM's mailing address is 3311 EAST OLD SHAKOPEE ROAD, MINNEAPOLIS MN, 55425. The company can be reached via phone at 952-853-8100 or via email at [email protected]